The use of hospital-prepared ophthalmic solution of 0.1% amphotericin B

The use of hospital-prepared ophthalmic solution of 0.1% amphotericin B - The use of hospital-prepared ophthalmic solution of 0.1% amphotericin B

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017319

Enrollment

Registered

2015-05-01

Start date

2015-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fungal keratitis

Interventions

To instill one drop of 0.1% amphotericin ophthalmic solution in patients&#39

eyes from four times per day to every one hour. The period of administration is until the lesion is healed or scarred.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Fungal keratitis patients with informed consent

Exclusion criteria

Exclusion criteria: The patients with a history of side effect by amphotericin B, or the cases that the doctor in charge concluded to be inappropriate for the research.

Design outcomes

Primary

Measure	Time frame
Clinical findings	—

Countries

Japan

Contacts

Public ContactDaisuke Todokoro

Gunma University Hospital Ophthalmology

dtodokor@gunma-u.ac.jp027-220-8338

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026